PL371584A1 - Ambroxol for treating painful conditions in the mouth and pharyngeal cavity - Google Patents

Ambroxol for treating painful conditions in the mouth and pharyngeal cavity

Info

Publication number
PL371584A1
PL371584A1 PL03371584A PL37158403A PL371584A1 PL 371584 A1 PL371584 A1 PL 371584A1 PL 03371584 A PL03371584 A PL 03371584A PL 37158403 A PL37158403 A PL 37158403A PL 371584 A1 PL371584 A1 PL 371584A1
Authority
PL
Poland
Prior art keywords
ambroxol
mouth
painful conditions
pharyngeal cavity
treating painful
Prior art date
Application number
PL03371584A
Other languages
Polish (pl)
Inventor
Anke Esperester
Uwe Pschorn
Jean-Michel Vix
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co.Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27740434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL371584(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma Gmbh & Co.Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co.Kg
Publication of PL371584A1 publication Critical patent/PL371584A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
PL03371584A 2002-02-27 2003-02-25 Ambroxol for treating painful conditions in the mouth and pharyngeal cavity PL371584A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10208313A DE10208313A1 (en) 2002-02-27 2002-02-27 Ambroxol for the treatment of painful conditions in the mouth and throat

Publications (1)

Publication Number Publication Date
PL371584A1 true PL371584A1 (en) 2005-06-27

Family

ID=27740434

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03371584A PL371584A1 (en) 2002-02-27 2003-02-25 Ambroxol for treating painful conditions in the mouth and pharyngeal cavity

Country Status (21)

Country Link
EP (1) EP1480626A1 (en)
JP (1) JP2005518435A (en)
KR (1) KR20040084944A (en)
CN (1) CN1638749A (en)
AR (1) AR038698A1 (en)
AU (1) AU2003210345B2 (en)
BR (1) BR0308038A (en)
CA (1) CA2477105A1 (en)
DE (1) DE10208313A1 (en)
EC (1) ECSP045242A (en)
IS (1) IS7417A (en)
MX (1) MXPA04008220A (en)
MY (1) MY144781A (en)
PE (1) PE20030830A1 (en)
PL (1) PL371584A1 (en)
RU (1) RU2311176C2 (en)
TW (1) TW200306804A (en)
UA (1) UA86741C2 (en)
UY (1) UY27679A1 (en)
WO (1) WO2003072094A1 (en)
ZA (1) ZA200405635B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10332486A1 (en) * 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of acute pain
JP2005120063A (en) * 2003-10-14 2005-05-12 Boehringer Ingelheim Pharma Gmbh & Co Kg Ambroxol for treating inflammation at pharynx
ITMI20032462A1 (en) * 2003-12-16 2005-06-17 Advance Holdings Ltd METHOD TO PREPARE A CARAMEL CONTAINING AMBROXOLO AND THE CANDY SO OBTAINED
DE102004021992A1 (en) * 2004-05-03 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Topical preparation containing ambroxol
JP2007084471A (en) * 2005-09-21 2007-04-05 Sunstar Inc Composition for oral cavity and method of selecting product for oral cavity
WO2007110871A2 (en) * 2006-03-29 2007-10-04 Naveh Pharma (1996) Ltd. Methods and composition for treating sore throat
JP5765934B2 (en) * 2009-12-28 2015-08-19 サンスター株式会社 Oral composition
JP6171683B2 (en) * 2012-08-03 2017-08-02 大正製薬株式会社 Solid preparation
CN105769908B (en) * 2016-05-06 2019-03-01 湖北凤凰白云山药业有限公司 A kind of drug of preventing phlegm from forming and stopping coughing and preparation method thereof
WO2018089797A1 (en) 2016-11-14 2018-05-17 Mingwu Wang Formulations for the treatment of ocular surface diseases and related methods
CN106727621A (en) * 2016-11-22 2017-05-31 郑州仁宏医药科技有限公司 A kind of Western medicine powder for treating toothache
JP6844394B2 (en) * 2017-04-14 2021-03-17 大正製薬株式会社 Solid composition
EP3415143A1 (en) 2017-06-16 2018-12-19 Kai-Uwe Kern Bromhexine for the treatment of pain

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485756D1 (en) * 1983-09-17 1992-07-09 Thomae Gmbh Dr K ANTIADHAESIVE PROPHYLACTICA AND MEDICINAL PRODUCTS CONTAINING A SECRETOLYTICALLY EFFECTIVE BENZYLAMINE DERIVATIVE.
DE3445226A1 (en) * 1983-12-14 1985-08-01 Reifenrath, Rainer Richard Otto, Dr.med., 7920 Heidenheim Pharmaceutical product for the treatment and prophylaxis of infections and of coughs and obstructive airway disorders
US5122540A (en) * 1986-02-28 1992-06-16 W. Keith R. Watson Method and composition for treating warts and throat soreness with DMSO and citric acid
DE4415553A1 (en) * 1994-05-03 1995-11-09 Behringwerke Ag Use of deoxyspergualin to prepare medicament
WO1997041832A1 (en) * 1996-05-02 1997-11-13 Taisho Pharmaceutical Co., Ltd. Suspension of sparingly water-soluble acidic drug
DE19933148A1 (en) * 1999-07-20 2001-01-25 Boehringer Ingelheim Int Lozenge containing ambroxol
JP2001151677A (en) * 1999-11-26 2001-06-05 Taisho Pharmaceut Co Ltd Composition for pharyngeal use
DE20102817U1 (en) * 2000-02-23 2001-06-07 Bolder Arzneimittel Gmbh Lozenges and chewing pills with cyclodextrin
US6391886B1 (en) * 2000-12-04 2002-05-21 The Procter & Gamble Company Oral compositions having improved consumer aesthetics

Also Published As

Publication number Publication date
PE20030830A1 (en) 2003-10-31
AU2003210345A1 (en) 2003-09-09
RU2004129284A (en) 2005-06-10
EP1480626A1 (en) 2004-12-01
UA86741C2 (en) 2009-05-25
DE10208313A1 (en) 2003-09-11
ECSP045242A (en) 2004-09-28
KR20040084944A (en) 2004-10-06
BR0308038A (en) 2004-12-28
CN1638749A (en) 2005-07-13
MXPA04008220A (en) 2004-11-26
WO2003072094A1 (en) 2003-09-04
AU2003210345B2 (en) 2009-01-29
JP2005518435A (en) 2005-06-23
RU2311176C2 (en) 2007-11-27
MY144781A (en) 2011-11-15
IS7417A (en) 2004-08-19
UY27679A1 (en) 2003-09-30
CA2477105A1 (en) 2003-09-04
ZA200405635B (en) 2005-05-31
AR038698A1 (en) 2005-01-26
TW200306804A (en) 2003-12-01

Similar Documents

Publication Publication Date Title
AU2003219931A8 (en) Sleep apnea device and method thereof
AU2003272187A8 (en) Novel nanoparticles and use thereof
AU2003228445A8 (en) Tissue composites and uses thereof
EP1543034A4 (en) Treatment and prophylaxis with 4-1bb-binding agents
HK1076248A1 (en) Use of rimexolone in the treatment of dry eye
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
ZA200410409B (en) Use of thio-oxindole derivatives in treatment of hormonerelated conditions
PL371584A1 (en) Ambroxol for treating painful conditions in the mouth and pharyngeal cavity
EP1578257A4 (en) Tissue retractor and method for using the retractor
IL159879A0 (en) Use of bibn4096 in combination with other antimigraine drugs for the treatment of migraine
GB0615918D0 (en) Composition and its therapeutic use
EP1558238A4 (en) Beta-hydroxyphenylaldylamines and their use for treating glaucoma
GB2411378B (en) Droplet-deposition related methods and appparatus
IL165112A0 (en) Variant integrinpolypeptides and thereof
IL155853A0 (en) Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
HUP0303610A3 (en) Remedies for vesical stimulation in association with prostatauxe
AU2003263895A8 (en) Contraceptive methods and formulations
AU2003302173A8 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
EP1531905A4 (en) Metallothionein based neuronal therapeutic and therapeutic methods
GB0220807D0 (en) Improvements in and relating to horseshoes
AU2003217432A8 (en) Angiopoietin-1 in the treatment of disease
GB0205826D0 (en) Therapeutic compositions and methods
IL166025A0 (en) Combination therapy and means for carrying out said therapy
IL174968A0 (en) The use of ifenprodil in the treatment of pain
GB2393658B (en) Penis holder and stretcher

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)